Regan J. Lauer

CIK: 0001200637

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (40.0%)

Derivative conversions

Awards (A)2 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IBRX

ImmunityBio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

IBRX
ImmunityBio, Inc.
Feb 22, 2026
Exercise(M)
Direct
4.1K shares-
IBRX
ImmunityBio, Inc.
Feb 22, 2026
Tax Payment(F)
Direct
1.7K shares at avg. $8.70$15K
IBRX
ImmunityBio, Inc.
Feb 10, 2026
Exercise(M)
Direct
5.5K shares-
IBRX
ImmunityBio, Inc.
Feb 10, 2026
Tax Payment(F)
Direct
2.3K shares at avg. $6.93$16K
IBRX
ImmunityBio, Inc.
Feb 22, 2025
Exercise(M)
Direct
4.1K shares-
IBRX
ImmunityBio, Inc.
Feb 22, 2025
Tax Payment(F)
Direct
1.7K shares at avg. $3.42$6K
IBRX
ImmunityBio, Inc.
Feb 10, 2025
Award(A)
Restricted Stock Units
Direct
16.4K shares-
IBRX
ImmunityBio, Inc.
Feb 10, 2025
Award(A)
Stock Option (right to buy)
Direct
56.3K shares-
IBRX
ImmunityBio, Inc.
Dec 15, 2024
Exercise(M)
Direct
21K shares-
IBRX
ImmunityBio, Inc.
Dec 15, 2024
Tax Payment(F)
Direct
7.5K shares at avg. $2.87$22K

		Type	Shares	Price		Ownership
Feb 22, 2026	IBRX ImmunityBio, Inc.	Exercise(M)	4,065	-	$0	Direct
Feb 22, 2026	IBRX ImmunityBio, Inc.	Tax Payment(F)	1,673	$8.70	$14,555	Direct
Feb 10, 2026	IBRX ImmunityBio, Inc.	Exercise(M)	5,482	-	$0	Direct
Feb 10, 2026	IBRX ImmunityBio, Inc.	Tax Payment(F)	2,257	$6.93	$15,641	Direct
Feb 22, 2025	IBRX ImmunityBio, Inc.	Exercise(M)	4,065	-	-	Direct
Feb 22, 2025	IBRX ImmunityBio, Inc.	Tax Payment(F)	1,669	$3.42	$5,708	Direct
Feb 10, 2025	IBRX ImmunityBio, Inc.	Award(A) Restricted Stock Units	16,447	-	-	Direct
Feb 10, 2025	IBRX ImmunityBio, Inc.	Award(A) Stock Option (right to buy)	56,250	-	-	Direct
Dec 15, 2024	IBRX ImmunityBio, Inc.	Exercise(M)	21,031	-	$0	Direct
Dec 15, 2024	IBRX ImmunityBio, Inc.	Tax Payment(F)	7,503	$2.87	$21,534	Direct

1-10 of 10 transactions

About LAUER REGAN J

LAUER REGAN J (SEC CIK 0001200637) files insider reports with the SEC as Chief Accounting Officer of ImmunityBio, Inc. (IBRX).

Signal8 holds 5 ownership filings by LAUER REGAN J, all Form 4s, filed between Dec 16, 2024 and Feb 24, 2026. Those filings report 10 transactions, from Dec 15, 2024 to Feb 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on LAUER REGAN J's filings is in SAN DIEGO, CA.

Recent filings by LAUER REGAN J

Feb 22, 2026: Option exercise of IBRX shares (Form 4, code M).
Feb 22, 2026: Tax withholding of IBRX shares (Form 4, code F).
Feb 10, 2026: Option exercise of IBRX shares (Form 4, code M).
Feb 10, 2026: Tax withholding of IBRX shares (Form 4, code F).
Feb 22, 2025: Option exercise of IBRX shares (Form 4, code M).

Other insiders filing for ImmunityBio, Inc. (IBRX)

Simon Barry J., Director
Cohen Cheryl, Director
Selecky Christobel, Director
BLASZYK MICHAEL D, Director
Wendel Bruce, Director
MAXWELL LINDA, Director

How to read Form 4 transaction codes